Found 63 hits with Last Name = 'paal' and Initial = 'm' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Calcium/calmodulin-dependent protein kinase type II subunit alpha/beta/delta/gamma
(Homo sapiens (Human)) | BDBM2579
((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)Show SMILES CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13 |r| Show InChI InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082930
(CHEMBL117662 | [6-(4-Carbamimidoyl-benzoylamino)-1...)Show SMILES NC(=N)c1ccc(cc1)C(=O)Nc1ccc2C(=O)C(CC(O)=O)CCc2c1 Show InChI InChI=1S/C20H19N3O4/c21-19(22)11-1-3-12(4-2-11)20(27)23-15-7-8-16-13(9-15)5-6-14(18(16)26)10-17(24)25/h1-4,7-9,14H,5-6,10H2,(H3,21,22)(H,23,27)(H,24,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082933
(CHEMBL323720 | [6-(4-Carbamimidoyl-benzoylamino)-c...)Show SMILES NC(=N)c1ccc(cc1)C(=O)Nc1ccc2OC(CC(O)=O)CCc2c1 Show InChI InChI=1S/C19H19N3O4/c20-18(21)11-1-3-12(4-2-11)19(25)22-14-6-8-16-13(9-14)5-7-15(26-16)10-17(23)24/h1-4,6,8-9,15H,5,7,10H2,(H3,20,21)(H,22,25)(H,23,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082933
(CHEMBL323720 | [6-(4-Carbamimidoyl-benzoylamino)-c...)Show SMILES NC(=N)c1ccc(cc1)C(=O)Nc1ccc2OC(CC(O)=O)CCc2c1 Show InChI InChI=1S/C19H19N3O4/c20-18(21)11-1-3-12(4-2-11)19(25)22-14-6-8-16-13(9-14)5-7-15(26-16)10-17(23)24/h1-4,6,8-9,15H,5,7,10H2,(H3,20,21)(H,22,25)(H,23,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082930
(CHEMBL117662 | [6-(4-Carbamimidoyl-benzoylamino)-1...)Show SMILES NC(=N)c1ccc(cc1)C(=O)Nc1ccc2C(=O)C(CC(O)=O)CCc2c1 Show InChI InChI=1S/C20H19N3O4/c21-19(22)11-1-3-12(4-2-11)20(27)23-15-7-8-16-13(9-15)5-6-14(18(16)26)10-17(24)25/h1-4,7-9,14H,5-6,10H2,(H3,21,22)(H,23,27)(H,24,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50058914
(CHEMBL303597 | [6-(4-Carbamimidoyl-benzoylamino)-1...)Show SMILES NC(=N)c1ccc(cc1)C(=O)Nc1ccc2C(=O)N(CC(O)=O)CCc2c1 Show InChI InChI=1S/C19H18N4O4/c20-17(21)11-1-3-12(4-2-11)18(26)22-14-5-6-15-13(9-14)7-8-23(19(15)27)10-16(24)25/h1-6,9H,7-8,10H2,(H3,20,21)(H,22,26)(H,24,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085605
(CHEMBL126411 | [6-(4-Carbamimidoyl-2-fluoro-benzoy...)Show SMILES NC(=N)c1ccc(C(=O)Nc2ccc3C(=O)C(CC(O)=O)CCc3c2)c(F)c1 Show InChI InChI=1S/C20H18FN3O4/c21-16-8-12(19(22)23)3-5-15(16)20(28)24-13-4-6-14-10(7-13)1-2-11(18(14)27)9-17(25)26/h3-8,11H,1-2,9H2,(H3,22,23)(H,24,28)(H,25,26) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082931
(CHEMBL148205 | [6-(4-Carbamimidoyl-benzoylamino)-3...)Show SMILES NC(=N)c1ccc(cc1)C(=O)Nc1ccc2CN(CC(O)=O)CCc2c1 Show InChI InChI=1S/C19H20N4O3/c20-18(21)12-1-3-13(4-2-12)19(26)22-16-6-5-15-10-23(11-17(24)25)8-7-14(15)9-16/h1-6,9H,7-8,10-11H2,(H3,20,21)(H,22,26)(H,24,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082932
(CHEMBL147258 | [6-(4-Carbamimidoyl-benzoylamino)-1...)Show SMILES NC(=N)c1ccc(cc1)C(=O)Nc1ccc2CC(CC(O)=O)CCc2c1 Show InChI InChI=1S/C20H21N3O3/c21-19(22)13-3-5-14(6-4-13)20(26)23-17-8-7-15-9-12(10-18(24)25)1-2-16(15)11-17/h3-8,11-12H,1-2,9-10H2,(H3,21,22)(H,23,26)(H,24,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085612
(CHEMBL126485 | [6-(4-Carbamimidoyl-2,6-difluoro-be...)Show SMILES NC(=N)c1cc(F)c(C(=O)Nc2ccc3C(=O)C(CC(O)=O)CCc3c2)c(F)c1 Show InChI InChI=1S/C20H17F2N3O4/c21-14-6-11(19(23)24)7-15(22)17(14)20(29)25-12-3-4-13-9(5-12)1-2-10(18(13)28)8-16(26)27/h3-7,10H,1-2,8H2,(H3,23,24)(H,25,29)(H,26,27) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
O94806/P05129/P05771/P17252/P24723/P41743/Q02156/Q04759/Q05513/Q05655/Q15139
(Homo sapiens (Human)) | BDBM2579
((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)Show SMILES CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13 |r| Show InChI InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibition of Cyclin E-cyclin-dependent kinase 2 |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085611
(CHEMBL127680 | {6-[(6-Carbamimidoyl-pyridine-3-car...)Show SMILES NC(=N)c1ccc(cn1)C(=O)Nc1ccc2C(=O)C(CC(O)=O)CCc2c1 Show InChI InChI=1S/C19H18N4O4/c20-18(21)15-6-3-12(9-22-15)19(27)23-13-4-5-14-10(7-13)1-2-11(17(14)26)8-16(24)25/h3-7,9,11H,1-2,8H2,(H3,20,21)(H,23,27)(H,24,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085614
(CHEMBL338485 | [6-(4-Carbamimidoyl-2-chloro-benzoy...)Show SMILES NC(=N)c1ccc(C(=O)Nc2ccc3C(=O)C(CC(O)=O)CCc3c2)c(Cl)c1 Show InChI InChI=1S/C20H18ClN3O4/c21-16-8-12(19(22)23)3-5-15(16)20(28)24-13-4-6-14-10(7-13)1-2-11(18(14)27)9-17(25)26/h3-8,11H,1-2,9H2,(H3,22,23)(H,24,28)(H,25,26) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 1/G2/mitotic-specific cyclin-B1/G2/mitotic-specific cyclin-B2/G2/mitotic-specific cyclin-B3
(Homo sapiens (Human)) | BDBM2579
((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)Show SMILES CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13 |r| Show InChI InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 2/G1/S-specific cyclin-E1/G1/S-specific cyclin-E2
(Homo sapiens (Human)) | BDBM2579
((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)Show SMILES CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13 |r| Show InChI InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibition of Cyclin E-cyclin-dependent kinase 2 |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
cAMP-dependent protein kinase catalytic subunit alpha/beta/gamma
(Homo sapiens (Human)) | BDBM2579
((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)Show SMILES CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13 |r| Show InChI InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibition of Protein kinase A |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Calcium/calmodulin-dependent protein kinase type II subunit alpha/beta/delta/gamma
(Homo sapiens (Human)) | BDBM2672
(3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21 Show InChI InChI=1S/C20H11N3O2/c24-19-15-13-9-5-1-3-7-11(9)21-17(13)18-14(16(15)20(25)23-19)10-6-2-4-8-12(10)22-18/h1-8,21-22H,(H,23,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibition of Cyclin E-cyclin-dependent kinase 2 |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085607
(CHEMBL126365 | [1-Oxo-6-((E)-3-piperidin-4-yl-acry...)Show SMILES OC(=O)CC1CCc2cc(NC(=O)\C=C\C3CCNCC3)ccc2C1=O Show InChI InChI=1S/C20H24N2O4/c23-18(6-1-13-7-9-21-10-8-13)22-16-4-5-17-14(11-16)2-3-15(20(17)26)12-19(24)25/h1,4-6,11,13,15,21H,2-3,7-10,12H2,(H,22,23)(H,24,25)/b6-1+ | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082927
(CHEMBL344117 | [6-(4-Carbamimidoyl-benzyloxy)-1-ox...)Show SMILES NC(=N)c1ccc(COc2ccc3C(=O)C(CC(O)=O)CCc3c2)cc1 Show InChI InChI=1S/C20H20N2O4/c21-20(22)13-3-1-12(2-4-13)11-26-16-7-8-17-14(9-16)5-6-15(19(17)25)10-18(23)24/h1-4,7-9,15H,5-6,10-11H2,(H3,21,22)(H,23,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082928
(CHEMBL439620 | [6-(4-Carbamimidoyl-benzyloxy)-3,4-...)Show InChI InChI=1S/C19H21N3O3/c20-19(21)14-3-1-13(2-4-14)12-25-17-6-5-16-10-22(11-18(23)24)8-7-15(16)9-17/h1-6,9H,7-8,10-12H2,(H3,20,21)(H,23,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082926
(CHEMBL144408 | [6-(4-Carbamimidoyl-benzyloxy)-chro...)Show InChI InChI=1S/C19H20N2O4/c20-19(21)13-3-1-12(2-4-13)11-24-15-7-8-17-14(9-15)5-6-16(25-17)10-18(22)23/h1-4,7-9,16H,5-6,10-11H2,(H3,20,21)(H,22,23) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM14187
(3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1ccc3ccccc3c21 Show InChI InChI=1S/C22H12N2O2/c25-21-18-16-12-6-2-1-5-11(12)9-10-14(16)20-17(19(18)22(26)24-21)13-7-3-4-8-15(13)23-20/h1-10,23H,(H,24,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM2579
((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)Show SMILES CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13 |r| Show InChI InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibition of Cyclin B-cyclin-dependent kinase 1 |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085610
(CHEMBL127200 | [1-Oxo-6-(3-piperidin-4-yl-propiony...)Show InChI InChI=1S/C20H26N2O4/c23-18(6-1-13-7-9-21-10-8-13)22-16-4-5-17-14(11-16)2-3-15(20(17)26)12-19(24)25/h4-5,11,13,15,21H,1-3,6-10,12H2,(H,22,23)(H,24,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085606
(CHEMBL127355 | [6-(4-Carbamimidoyl-2-trifluorometh...)Show SMILES NC(=N)c1ccc(C(=O)Nc2ccc3C(=O)C(CC(O)=O)CCc3c2)c(c1)C(F)(F)F Show InChI InChI=1S/C21H18F3N3O4/c22-21(23,24)16-8-12(19(25)26)3-5-15(16)20(31)27-13-4-6-14-10(7-13)1-2-11(18(14)30)9-17(28)29/h3-8,11H,1-2,9H2,(H3,25,26)(H,27,31)(H,28,29) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 72 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM2672
(3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21 Show InChI InChI=1S/C20H11N3O2/c24-19-15-13-9-5-1-3-7-11(9)21-17(13)18-14(16(15)20(25)23-19)10-6-2-4-8-12(10)22-18/h1-8,21-22H,(H,23,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM50134579
(11H-3-Thia-5,11-diaza-benzo[a]trindene-4,6-dione |...)Show InChI InChI=1S/C16H8N2O2S/c19-15-11-10-7-3-1-2-4-9(7)17-13(10)8-5-6-21-14(8)12(11)16(20)18-15/h1-6,17H,(H,18,19,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM50134578
(1,2,3,8-tetrahydropyrido[3,2-a]pyrrolo[4,3-c]carba...)Show InChI InChI=1S/C17H9N3O2/c21-16-12-11-8-4-1-2-6-10(8)19-15(11)9-5-3-7-18-14(9)13(12)17(22)20-16/h1-7,19H,(H,20,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Calcium/calmodulin-dependent protein kinase type II subunit alpha/beta/delta/gamma
(Homo sapiens (Human)) | BDBM2581
(3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^...)Show SMILES O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21 Show InChI InChI=1S/C20H13N3O/c24-20-17-12(9-21-20)15-10-5-1-3-7-13(10)22-18(15)19-16(17)11-6-2-4-8-14(11)23-19/h1-8,22-23H,9H2,(H,21,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL DrugBank MCE PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | 184 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085609
(CHEMBL128984 | {6-[(5-Carbamimidoyl-thiophene-2-ca...)Show SMILES NC(=N)c1ccc(s1)C(=O)Nc1ccc2C(=O)C(CC(O)=O)CCc2c1 Show InChI InChI=1S/C18H17N3O4S/c19-17(20)13-5-6-14(26-13)18(25)21-11-3-4-12-9(7-11)1-2-10(16(12)24)8-15(22)23/h3-7,10H,1-2,8H2,(H3,19,20)(H,21,25)(H,22,23) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| PubMed
| n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM14188
(3-thia-13,23-diazahexacyclo[14.7.0.0^{2,10}.0^{4,9...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1sc3ccccc3c21 Show InChI InChI=1S/C20H10N2O2S/c23-19-15-13-9-5-1-3-7-11(9)21-17(13)18-14(16(15)20(24)22-19)10-6-2-4-8-12(10)25-18/h1-8,21H,(H,22,23,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM50134576
(6,7,12,13-tetrahydro-5H-pyrido[3',2':4,5]pyrrolo[2...)Show SMILES O=C1NC(=O)c2c1c1c3ccc[nH]c3nc1c1[nH]c3ccccc3c21 Show InChI InChI=1S/C19H8N4O2/c24-18-13-11-8-4-1-2-6-10(8)21-15(11)16-12(14(13)19(25)23-18)9-5-3-7-20-17(9)22-16/h1-7H,(H,23,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082937
(CHEMBL356574 | [6-(4-Carbamimidoyl-benzyloxy)-1,2,...)Show InChI InChI=1S/C20H22N2O3/c21-20(22)15-4-1-13(2-5-15)12-25-18-8-7-16-9-14(10-19(23)24)3-6-17(16)11-18/h1-2,4-5,7-8,11,14H,3,6,9-10,12H2,(H3,21,22)(H,23,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM50134580
(1,2,3,8-tetrahydro-benzo[a]pyrrolo[3,4-c]carbazole...)Show InChI InChI=1S/C18H10N2O2/c21-17-14-9-5-1-2-6-10(9)16-13(15(14)18(22)20-17)11-7-3-4-8-12(11)19-16/h1-8,19H,(H,20,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibition of Cyclin E-cyclin-dependent kinase 2 |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 2/G1/S-specific cyclin-E1/G1/S-specific cyclin-E2
(Homo sapiens (Human)) | BDBM14187
(3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1ccc3ccccc3c21 Show InChI InChI=1S/C22H12N2O2/c25-21-18-16-12-6-2-1-5-11(12)9-10-14(16)20-17(19(18)22(26)24-21)13-7-3-4-8-15(13)23-20/h1-10,23H,(H,24,25,26) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 275 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085608
(CHEMBL338486 | [1-Oxo-6-(piperidin-4-ylmethoxycarb...)Show InChI InChI=1S/C19H24N2O5/c22-17(23)10-14-2-1-13-9-15(3-4-16(13)18(14)24)21-19(25)26-11-12-5-7-20-8-6-12/h3-4,9,12,14,20H,1-2,5-8,10-11H2,(H,21,25)(H,22,23) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM50134577
(1,2,3,4,5,6,7,12-octahydronaphtho[2,1-a]pyrrolo[4,...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1ccc3CCCCc3c21 Show InChI InChI=1S/C22H16N2O2/c25-21-18-16-12-6-2-1-5-11(12)9-10-14(16)20-17(19(18)22(26)24-21)13-7-3-4-8-15(13)23-20/h3-4,7-10,23H,1-2,5-6H2,(H,24,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 410 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM50134575
(7,8,9,14-tetrahydronaphtho[1,2-a]pyrrolo[4,3-c]car...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1c2ccc2ccccc12 Show InChI InChI=1S/C22H12N2O2/c25-21-18-14-10-9-11-5-1-2-6-12(11)16(14)20-17(19(18)22(26)24-21)13-7-3-4-8-15(13)23-20/h1-10,23H,(H,24,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 1/G2/mitotic-specific cyclin-B1/G2/mitotic-specific cyclin-B2/G2/mitotic-specific cyclin-B3
(Homo sapiens (Human)) | BDBM14187
(3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1ccc3ccccc3c21 Show InChI InChI=1S/C22H12N2O2/c25-21-18-16-12-6-2-1-5-11(12)9-10-14(16)20-17(19(18)22(26)24-21)13-7-3-4-8-15(13)23-20/h1-10,23H,(H,24,25,26) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 590 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibition of Cyclin B-cyclin-dependent kinase 1 |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082934
(CHEMBL342540 | [7-(4-Carbamimidoyl-benzyloxy)-1-ox...)Show SMILES NC(=N)c1ccc(COc2ccc3c(CCCN(CC(O)=O)C3=O)c2)cc1 Show InChI InChI=1S/C20H21N3O4/c21-19(22)14-5-3-13(4-6-14)12-27-16-7-8-17-15(10-16)2-1-9-23(20(17)26)11-18(24)25/h3-8,10H,1-2,9,11-12H2,(H3,21,22)(H,24,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50058911
(CHEMBL63887 | [6-(4-Carbamimidoyl-benzyloxy)-1-oxo...)Show SMILES NC(=N)c1ccc(COc2ccc3C(=O)N(CC(O)=O)CCc3c2)cc1 Show InChI InChI=1S/C19H19N3O4/c20-18(21)13-3-1-12(2-4-13)11-26-15-5-6-16-14(9-15)7-8-22(19(16)25)10-17(23)24/h1-6,9H,7-8,10-11H2,(H3,20,21)(H,23,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085604
(CHEMBL127181 | [1-Oxo-6-(3-piperidin-4-yl-propylam...)Show InChI InChI=1S/C20H28N2O3/c23-19(24)13-16-4-3-15-12-17(5-6-18(15)20(16)25)22-9-1-2-14-7-10-21-11-8-14/h5-6,12,14,16,21-22H,1-4,7-11,13H2,(H,23,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 610 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM50216165
(1,11-dihydro-1,3,5,11-tetraaza-benzo[a]trindene-4,...)Show InChI InChI=1S/C15H8N4O2/c20-14-9-8-6-3-1-2-4-7(6)18-12(8)13-11(16-5-17-13)10(9)15(21)19-14/h1-5,18H,(H,16,17)(H,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 740 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM2581
(3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^...)Show SMILES O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21 Show InChI InChI=1S/C20H13N3O/c24-20-17-12(9-21-20)15-10-5-1-3-7-13(10)22-18(15)19-16(17)11-6-2-4-8-14(11)23-19/h1-8,22-23H,9H2,(H,21,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL DrugBank MCE PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | 830 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 2/G1/S-specific cyclin-E1/G1/S-specific cyclin-E2
(Homo sapiens (Human)) | BDBM2672
(3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21 Show InChI InChI=1S/C20H11N3O2/c24-19-15-13-9-5-1-3-7-11(9)21-17(13)18-14(16(15)20(25)23-19)10-6-2-4-8-12(10)22-18/h1-8,21-22H,(H,23,24,25) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibition of Cyclin B-cyclin-dependent kinase 1 |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 2/G1/S-specific cyclin-E1/G1/S-specific cyclin-E2
(Homo sapiens (Human)) | BDBM2581
(3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^...)Show SMILES O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21 Show InChI InChI=1S/C20H13N3O/c24-20-17-12(9-21-20)15-10-5-1-3-7-13(10)22-18(15)19-16(17)11-6-2-4-8-14(11)23-19/h1-8,22-23H,9H2,(H,21,24) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL DrugBank MCE PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 1/G2/mitotic-specific cyclin-B1/G2/mitotic-specific cyclin-B2/G2/mitotic-specific cyclin-B3
(Homo sapiens (Human)) | BDBM2672
(3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^...)Show SMILES O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21 Show InChI InChI=1S/C20H11N3O2/c24-19-15-13-9-5-1-3-7-11(9)21-17(13)18-14(16(15)20(25)23-19)10-6-2-4-8-12(10)22-18/h1-8,21-22H,(H,23,24,25) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibitory activity against Cyclin D1-cyclin-dependent kinase 4 by measuring the phosphorylation of RbING |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50082935
(CHEMBL147218 | [5-(4-Carbamimidoyl-benzyloxy)-1-ox...)Show SMILES NC(=N)c1ccc(COc2ccc3C(=O)N(CC(O)=O)Cc3c2)cc1 Show InChI InChI=1S/C18H17N3O4/c19-17(20)12-3-1-11(2-4-12)10-25-14-5-6-15-13(7-14)8-21(18(15)24)9-16(22)23/h1-7H,8-10H2,(H3,19,20)(H,22,23) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) |
J Med Chem 42: 4875-89 (1999)
BindingDB Entry DOI: 10.7270/Q2NC60DZ |
More data for this Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50085613
(CHEMBL126998 | {1-Oxo-6-[2-(piperidin-4-yloxy)-ace...)Show InChI InChI=1S/C19H24N2O5/c22-17(11-26-15-5-7-20-8-6-15)21-14-3-4-16-12(9-14)1-2-13(19(16)25)10-18(23)24/h3-4,9,13,15,20H,1-2,5-8,10-11H2,(H,21,22)(H,23,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company
Curated by ChEMBL
| Assay Description Inhibition of fibrinogen binding to purified human GPIIb-IIIa in ELISA |
Bioorg Med Chem Lett 10: 385-9 (2000)
BindingDB Entry DOI: 10.7270/Q2FB5252 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4/G1/S-specific cyclin-D1
(Homo sapiens (Human)) | BDBM50134582
(1,2,3,8-tetrahydropyrido[3,4-a]pyrrolo[4,3-c]carba...)Show InChI InChI=1S/C17H9N3O2/c21-16-13-8-5-6-18-7-10(8)15-12(14(13)17(22)20-16)9-3-1-2-4-11(9)19-15/h1-7,19H,(H,20,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.81E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Lilly Spain S.A.
Curated by ChEMBL
| Assay Description Inhibition of Cyclin E-cyclin-dependent kinase 2 |
Bioorg Med Chem Lett 13: 3835-9 (2003)
BindingDB Entry DOI: 10.7270/Q2Z89BTC |
More data for this Ligand-Target Pair | |